Zhi-liang L. Gao

600 Tianhe Road
Guangzhou, 510630, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Mesenchymal stem cells-derived TGF-β1 promotes polarization of M2 macrophages in mice with acute-on-chronic liver failure via FOSL1/MERTK axis.

Mesenchymal stem cells-derived TGF-β1 promotes polarization of M2 macrophages in mice with acute-on-chronic liver failure via FOSL1/MERTK axis.

Journal: Stem cell research & therapy

Published: September 27, 2025

Mesenchymal Stem Cells Promote Polarization of M2 Macrophages in Mice with Acute-On-Chronic Liver Failure via Mertk/JAK1/STAT6 Signaling.

Mesenchymal Stem Cells Promote Polarization of M2 Macrophages in Mice with Acute-On-Chronic Liver Failure via Mertk/JAK1/STAT6 Signaling.

Journal: Stem cells (Dayton, Ohio)

Published: April 22, 2023

LAG3+ erythroid progenitor cells inhibit HBsAg seroclearance during finite pegylated interferon treatment through LAG3 and TGF-β.

LAG3+ erythroid progenitor cells inhibit HBsAg seroclearance during finite pegylated interferon treatment through LAG3 and TGF-β.

Journal: Antiviral research

Published: October 06, 2022

Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue.

Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue.

Journal: Liver research (Beijing, China)

Published: July 19, 2022

Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.

Real-world study on HBsAg loss of combination therapy in HBeAg-negative chronic hepatitis B patients.

Journal: Journal of viral hepatitis

Published: February 16, 2022

Transforming growth factor-β: An early predictor of a functional cure in chronic hepatitis B treated with interferon.

Transforming growth factor-β: An early predictor of a functional cure in chronic hepatitis B treated with interferon.

Journal: Virus research

Published: November 11, 2021

Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial.

Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial.

Journal: Hepatology international

Published: November 06, 2021

The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients.

The clinical value of serum hepatic parenchyma cell volume-normalized hepatitis B surface antigen levels in hepatitis B e antigen -positive and -negative chronic hepatitis B patients.

Journal: Annals of translational medicine

Published: July 09, 2021

The impact of serum thyroid-stimulation hormone levels on the outcome of hepatitis B virus related acute-on-chronic liver failure: an observational study.

The impact of serum thyroid-stimulation hormone levels on the outcome of hepatitis B virus related acute-on-chronic liver failure: an observational study.

Journal: BMC gastroenterology

Published: May 23, 2021

Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.

Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.

Journal: Gut microbes

Published: May 19, 2021

The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α.

The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α.

Journal: Annals of translational medicine

Published: April 12, 2021

Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure.

Derivation and Validation of a Nomogram for Predicting 90-Day Survival in Patients With HBV-Related Acute-on-Chronic Liver Failure.

Journal: Frontiers in medicine

Published: April 08, 2021

Showing 1-12 of 76

Last Updated: 09/26/2026